| Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies J Naidoo, DB Page, BT Li, LC Connell, K Schindler, ME Lacouture, ... Annals of Oncology 26 (12), 2375-2391, 2015 | 1532 | 2015 |
| The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment LC Connell, JM Mota, MI Braghiroli, PM Hoff Current treatment options in oncology 18, 1-20, 2017 | 221 | 2017 |
| A comprehensive comparison of early-onset and average-onset colorectal cancers A Cercek, WK Chatila, R Yaeger, H Walch, GDS Fernandes, A Krishnan, ... JNCI: Journal of the National Cancer Institute 113 (12), 1683-1692, 2021 | 93 | 2021 |
| Advanced hepatocellular cancer: the current state of future research LC Connell, JJ Harding, GK Abou-Alfa Current treatment options in oncology 17, 1-16, 2016 | 63 | 2016 |
| Phase II single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair–proficient metastatic colorectal cancer NH Segal, A Cercek, G Ku, AJ Wu, A Rimner, DN Khalil, D Reidy-Lagunes, ... Clinical Cancer Research 27 (8), 2200-2208, 2021 | 62 | 2021 |
| Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies A Cercek, TM Boucher, JS Gluskin, A Aguiló, JF Chou, LC Connell, ... Journal of surgical oncology 114 (6), 655-663, 2016 | 50 | 2016 |
| Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma LC Connell, JJ Harding, J Shia, GK Abou-Alfa Chinese Clinical Oncology 5 (5), 66-66, 2016 | 42 | 2016 |
| Intrahepatic cholangiocarcinoma with lymph node metastasis: treatment-related outcomes and the role of tumor genomics in patient selection JS Jolissaint, KC Soares, KP Seier, R Kundra, M Gönen, PJ Shin, ... Clinical Cancer Research 27 (14), 4101-4108, 2021 | 28 | 2021 |
| Characterization and clinical outcomes of DNA mismatch repair–deficient small bowel adenocarcinoma A Latham, J Shia, Z Patel, DL Reidy-Lagunes, NH Segal, R Yaeger, ... Clinical Cancer Research 27 (5), 1429-1437, 2021 | 26 | 2021 |
| Development and assessment of a clinical calculator for estimating the likelihood of recurrence and survival among patients with locally advanced rectal cancer treated with … MR Weiser, JF Chou, A Keshinro, WC Chapman, PS Bauer, MG Mutch, ... JAMA Network Open 4 (11), e2133457-e2133457, 2021 | 22 | 2021 |
| Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases LC Connell, TM Boucher, JF Chou, M Capanu, S Maldonado, NE Kemeny Journal of surgical oncology 115 (4), 480-487, 2017 | 21 | 2017 |
| Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion JJ Smith, WK Chatila, F Sanchez‐Vega, J Datta, LC Connell, BC Szeglin, ... Cancer Medicine 8 (15), 6538-6548, 2019 | 9 | 2019 |
| A randomized phase II trial of adjuvant hepatic arterial infusion and systemic therapy with or without panitumumab after hepatic resection of KRAS wild-type colorectal cancer NE Kemeny, JF Chou, M Capanu, WK Chatila, H Shi, F Sanchez-Vega, ... Annals of surgery 274 (2), 248-254, 2021 | 5 | 2021 |
| Impact of primary tumor laterality on adjuvant hepatic artery infusion pump chemotherapy in resected colon cancer liver metastases: analysis of 487 patients S Gholami, S Stewart, N Kemeny, M Gönen, B Groot Koerkamp, A Cercek, ... Annals of surgical oncology 28, 3685-3694, 2021 | 4 | 2021 |
| Early liver metastases after “failure” of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? T Boerner, C Zambirinis, J Gagnière, JF Chou, M Gonen, NE Kemeny, ... HPB 23 (4), 601-608, 2021 | 4 | 2021 |
| Intraarterial chemotherapy for liver metastases LC Connell, NE Kemeny Surgical Oncology Clinics 30 (1), 143-158, 2021 | 4 | 2021 |
| Platinum-based combination therapy (PCT) and outcomes for patients (pts) with mixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma (mHCC/ICC). LC Connell, JJ Harding, MA Lowery, NE Kemeny, A Cercek, ... Journal of Clinical Oncology 33 (15_suppl), e15146-e15146, 2015 | 4 | 2015 |
| Cost effectiveness and cancer drugs. JE Battley, LC Connell, DM Graham, S O'Reilly Journal of Clinical Oncology: Official Journal of the American Society of …, 2014 | 4 | 2014 |
| A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma. A Cercek, ZK Stadler, JL Cohen, JA Weiss, MF Lamendola-Essel, ... Journal of Clinical Oncology 38 (15_suppl), TPS4123-TPS4123, 2020 | 3 | 2020 |
| Characterization and clinical outcomes of mismatch repair deficient (dMMR) small bowel adenocarcinoma (SBA). A Latham, DL Reidy, NH Segal, R Yaeger, K Ganesh, LC Connell, ... Journal of Clinical Oncology 37 (15_suppl), 1511-1511, 2019 | 3 | 2019 |
